These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 36291944)

  • 41. Identifying immune infiltration by deep learning to assess the prognosis of patients with hepatocellular carcinoma.
    Jia W; Shi W; Yao Q; Mao Z; Chen C; Fan A; Wang Y; Zhao Z; Li J; Song W
    J Cancer Res Clin Oncol; 2023 Nov; 149(14):12621-12635. PubMed ID: 37450030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8
    Wang M; Zhai R; Wang M; Zhu W; Zhang J; Yu M; Zhang W; Ye J; Liu L
    Mol Oncol; 2023 Aug; 17(8):1514-1530. PubMed ID: 36825382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding.
    Hou X; Li X; Han Y; Xu H; Xie Y; Zhou T; Xue T; Qian X; Li J; Wang HC; Yan J; Guo X; Liu Y; Liu J
    Cancer; 2024 Apr; 130(S8):1499-1512. PubMed ID: 38422056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma.
    Yao Y; Xuan H; Wang J; Gong L; Gao W
    Tumori; 2023 Oct; 109(5):466-480. PubMed ID: 37249074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection and quantitative analysis of tumor-associated tertiary lymphoid structures.
    Yang M; Che Y; Li K; Fang Z; Li S; Wang M; Zhang Y; Xu Z; Luo L; Wu C; Lai X; Wang W
    J Zhejiang Univ Sci B; 2023 Sept 15; 24(9):779-795. PubMed ID: 37701955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BTBD10 is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma.
    Li J; Tian X; Nie Y; He Y; Wu W; Lei X; Zhang T; Wang Y; Mao Z; Zhang H; Zhang X; Song W
    Front Mol Biosci; 2021; 8():762541. PubMed ID: 35059434
    [No Abstract]   [Full Text] [Related]  

  • 47. Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures.
    Magara T; Nakamura M; Nojiri Y; Yoshimitsu M; Kano S; Kato H; Morita A
    Front Oncol; 2023; 13():1106434. PubMed ID: 37081973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer.
    Masuda T; Tanaka N; Takamatsu K; Hakozaki K; Takahashi R; Anno T; Kufukihara R; Shojo K; Mikami S; Shinojima T; Kakimi K; Tsunoda T; Aimono E; Nishihara H; Mizuno R; Oya M
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35314433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics and clinical significance of tertiary lymphoid structures in OSCC.
    Yao M; Yang T; Li Q; Zhang X; Zheng Z; Li J; Huang J; Sun Y; Gao X; Fang C
    Oral Dis; 2024 Jul; ():. PubMed ID: 39049571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance.
    Zou X; Lin X; Cheng H; Chen Y; Wang R; Ma M; Liu Y; Dai Z; Tasiheng Y; Yan Y; Hou Q; Ding F; Chen H; Yu X; Wang X; Liu C
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37364934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and Validation of a Machine Learning Model for Detection and Classification of Tertiary Lymphoid Structures in Gastrointestinal Cancers.
    Li Z; Jiang Y; Li B; Han Z; Shen J; Xia Y; Li R
    JAMA Netw Open; 2023 Jan; 6(1):e2252553. PubMed ID: 36692877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer.
    Song IH; Heo SH; Bang WS; Park HS; Park IA; Kim YA; Park SY; Roh J; Gong G; Lee HJ
    Cancer Res Treat; 2017 Apr; 49(2):399-407. PubMed ID: 27488875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Absence of Intra-Tumoral Tertiary Lymphoid Structures is Associated with a Worse Prognosis and mTOR Signaling Activation in Hepatocellular Carcinoma with Liver Transplantation: A Multicenter Retrospective Study.
    Li J; Zhang L; Xing H; Geng Y; Lv S; Luo X; He W; Fu Z; Li G; Hu B; Jiang S; Yang Z; Zhu N; Zhang Q; Zhao J; Tao Y; Shen C; Li R; Tang F; Zheng S; Bao Y; He Q; Geng D; Wang Z
    Adv Sci (Weinh); 2024 Jun; 11(21):e2309348. PubMed ID: 38498682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD8
    Li Q; Zhang D; He W; Chen T; Yan Z; Gao X; Chen L; Zheng X; Xu B; Lu B; Jiang J
    Oncol Lett; 2020 Sep; 20(3):2655-2664. PubMed ID: 32782582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development.
    Hill DG; Yu L; Gao H; Balic JJ; West A; Oshima H; McLeod L; Oshima M; Gallimore A; D'Costa K; Bhathal PS; Sievert W; Ferrero RL; Jenkins BJ; Jones GW
    Int J Cancer; 2018 Jul; 143(1):167-178. PubMed ID: 29417587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heterogeneity of Cervical Cancer-Associated Tertiary Lymphoid Structures (TLSs) and Their Specific Interrelation With Clinicopathological Parameters.
    Bălan L; Cimpean AM; Secosan C; Sorop VB; Balan C; Moldovan M; Melnic E; Balulescu L; Brasoveanu S; Pirtea L
    Cureus; 2024 Apr; 16(4):e59077. PubMed ID: 38694662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope.
    Jia W; Zhang T; Yao Q; Li J; Nie Y; Lei X; Mao Z; Wang Y; Shi W; Song W
    Front Immunol; 2022; 13():870458. PubMed ID: 35844587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer.
    Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
    Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tertiary Lymphoid Structures: A Potential Biomarker for Anti-Cancer Therapy.
    Zou J; Zhang Y; Zeng Y; Peng Y; Liu J; Xiao C; Wu F
    Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-dose radiotherapy promotes the formation of tertiary lymphoid structures in lung adenocarcinoma.
    Wang D; Huang L; Qian D; Cao Y; Wu X; Xu P; Ming L; Tang J; Huang Z; Yin Y; Zhou L
    Front Immunol; 2023; 14():1334408. PubMed ID: 38259481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.